Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Unknown status
NCT03016611
Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study
100
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome
STEMI
Completed
NCT01957540
Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease
22
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Endothelial Function
Completed
NCT01785472
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension
1,438
Enrollment(s)
50
Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT02212028
Pharmacological Effects of Crushing Prasugrel in STEMI Patients
52
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Unknown status
NCT02996916
Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue
100
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
Completed
NCT02962336
Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.
34
Enrollment(s)
0
Study location(s)
Interventional (Phase I)
Healthy Subjects
Completed
NCT02962258
BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions
34
Enrollment(s)
0
Study location(s)
Interventional (Phase I)
Healthy Subjects
Completed
NCT02955498
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects
32
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Healthy Male Subjects
76
77
78
79
80